Litcius/Paper detail

Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways

Litao Wu, Juan Sun, Li Liu, Xiaojuan Du, Yan Liu, Xiaofei Yan, Ezra Kombo Osoro, Fujun Zhang, Lina Feng, Dong Liang, Yazhao Li, Qian Chen, Sha Sun, Lei Zhang, Xi Lan, Dongmin Li, Shemin Lu

2020International Immunopharmacology22 citationsDOI

Topics & Concepts

SteatosisInflammationFatty liverTLR2Internal medicineSteatohepatitisFibrosisEndocrinologyLiver injuryNonalcoholic fatty liver diseaseBiologyMedicineTLR4DiseaseLiver Disease Diagnosis and TreatmentDiabetes and associated disordersLipid metabolism and disorders
Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways | Litcius